Due to its impressive properties such as a high absorption coefficient, long diffusion length and low exciton dissociation energy, [2] the perovskite has been exploited in several applications, among them light amplifiers and lasers, [3-,5] light emitting diodes (LEDs), [6-8] and photovoltaic devices. [9,10] The halide perovskite structure, ABX 3 [11] allows multiple atom combinations, making it very versatile. In addition, it can be synthesized at a low temperature permitting a relatively easy synthesis by a broad range of methods. The monovalent cation A (formamidinium [FA], [12] methylammonium [MA], [13] or cesium [14]) is located in the cage of BX 6 4− octahedra, where B is the metal (commonly, lead or tin) and X a halide or combination of them. The most studied hybrid-perovskite materials are MAPbI 3 and FAPbI 3. Both compounds result in a perovskite structure, despite the difference in the tolerance factor (0.95 and 1.03, respectively, and the same octahedral factor. [15,16] MAPbI 3 is intrinsically phase stable at ambient Formamidinium-based perovskite solar cells (PSCs) present the maximum theoretical efficiency of the lead perovskite family. However, formamidinium perovskite exhibits significant degradation in air. The surface chemistry of PbS has been used to improve the formamidinium black phase stability. Here, the use of PbS nanoplatelets with (100) preferential crystal orientation is reported, to potentiate the repercussion on the crystal growth of perovskite grains and to improve the stability of the material and consequently of the solar cells. As a result, a vertical growth of perovskite grains, a stable current density of 23 mA cm −2 , and a stable incident photon to current efficiency in the infrared region of the spectrum for 4 months is obtained, one of the best stability achievements for planar PSCs. Moreover, a better reproducibility than the control device, by optimizing the PbS concentration in the perovskite matrix, is achieved. These outcomes validate the synergistic use of PbS nanoplatelets to improve formamidinium long-term stability and performance reproducibility, and pave the way for using metastable perovskite active phases preserving their light harvesting capability.
α-CsPbI3 quantum dots (QDs) show outstanding photoelectrical properties that had been harnessed in the fabrication of perovskite QDs solar cells. Nevertheless, the stabilization of the CsPbI3 perovskite cubic phase remains a challenge due to its own thermodynamic and the presence of surface defects. Herein, we report the optimization of the CsPbI3 QDs solar cells, by monitoring the structure, the morphology and the optoelectronic properties after a precise treatment, consisting of the conventional solvent washing with a time limited ultraviolet (UV) exposure combination, during the layer-by-layer deposition. The UV treatment compensates the defects coming from the essential but deleterious washing treatment. The material is stable for 200 h and the PCE improved by the 25% compared with that of the device without UV treatment. The photo-enhanced ion mobility mechanism is discussed as the main process for the CsPbI3 QDs and solar cell stability.
Zinc oxide (ZnO) has interesting optoelectronic properties, but suffers from chemical instability when in contact with perovskite interfaces; hence, the perovskite deposited on the top degrades promptly. Surface passivation strategies alleviate this instability issue; however, synthesis to passivate ZnO nanoparticles (NPs) in situ has received less attention. Here, a new synthesis at low temperatures with an ethanolamine post treatment has been developed. By using ZnO NPs prepared with ethanolamine and butanol (BuOH), (E-ZnO), the stability of the FA0.9Cs0.1PbI3 (FACsPI)–ZnO interface was achieved, with a photoconversion efficiency of >18%. Impedance spectroscopy demonstrates that the recombination at the interface was reduced in the system with E-ZnO/perovskite compared to common SnO2/perovskite and that the quality of the perovskite on the top is clearly due to the ZnO in situ passivation with ethanolamine. This work extends the use of E-ZnO as an n-type charge extraction layer and demonstrates its feasibility with methylammonium perovskite. Moreover, this study paves the way for other in situ passivation methods with different target molecules, along with new insights regarding the perovskite interface rearrangement when in contact with the modified electron transport layer (ETL).
The synthesis of halide perovskite nanocrystals (PNCs) with mesmerizing photophysical properties has allowed for the fast development of efficient optoelectronic and photovoltaic devices, as well as making them ideal photocatalysts for solar-driven chemical reactions. However, the use of traditional oleic acid/oleylamine with low binding energy and the introduction of some phosphine- and sulfur-based ligands generate the emergence of highly defective PNCs with poor stability, fast quenching of their PL features, and increase in the toxicity of the final perovskite product. In this review, we will show the use of prominent “green” and ecofriendly solvents and capping ligands with the capability to enhance the quality of the PNCs by suppressing structural defects. By introducing promising ecofriendly agents such as biogenic species and ligands extracted from natural sources, it is possible to favor the radiative recombination dynamics into the perovskite, being beneficial to enhance the device performance. Novel passivation alternatives or synthetic routes are highlighted in this contribution, giving a deeper understanding of the control of surface chemistry in PNCs through ligand engineering to prolong the stability of the nanocrystals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.